Coherus Oncology, Inc. (CHRS): Weighted Average Diluted Shares
117.14M
Year ended 2025-12-31
+14.7%
3-year compound annual growth
+7.0%
5-year compound annual growth
| Period ended | Weighted Average Diluted Shares | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 117.14M | +2.3% | 2026-03-09, From 2025-01-01 |
| 2024-12-31 | 114.55M | +21.7% | 2026-03-09, From 2024-01-01 |
| 2023-12-31 | 94.16M | +21.3% | 2025-03-17, From 2023-01-01 |
| 2022-12-31 | 77.63M | +2.9% | 2025-03-17, From 2022-01-01 |
| 2021-12-31 | 75.45M | -9.6% | 2024-03-15, From 2021-01-01 |
| 2020-12-31 | 83.49M | +14.1% | 2023-03-06, From 2020-01-01 |
| 2019-12-31 | 73.19M | +12.5% | 2022-02-23, From 2019-01-01 |
| 2018-12-31 | 65.03M | +22.4% | 2021-02-25, From 2018-01-01 |
| 2017-12-31 | 53.13M | n/a | 2020-02-27, From 2017-01-01 |